H J de Koning

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. ncbi Early detection and counselling intervention of asthma symptoms in preschool children: study design of a cluster randomised controlled trial
    Esther Hafkamp-de Groen
    The Generation R Study Group, Erasmus MC, Rotterdam, The Netherlands
    BMC Public Health 10:555. 2010
  2. ncbi Bracing patients with idiopathic scoliosis: design of the Dutch randomized controlled treatment trial
    Eveline M Bunge
    Erasmus MC, University Medical Center Rotterdam, Dept of Public Health, P O Box 2040, 3000 CA Rotterdam, The Netherlands
    BMC Musculoskelet Disord 9:57. 2008
  3. ncbi Monitoring the ERSPC trial
    H J de Koning
    Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
    BJU Int 92:112-4. 2003
  4. ncbi Determining the cause of death in randomized screening trial(s) for prostate cancer
    H J de Koning
    Erasmus MC, Department Public Health, Rotterdam, The Netherlands
    BJU Int 92:71-8. 2003
  5. ncbi Mammographic screening: evidence from randomised controlled trials
    H J de Koning
    Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands
    Ann Oncol 14:1185-9. 2003
  6. ncbi Overdiagnosis and overtreatment of breast cancer: microsimulation modelling estimates based on observed screen and clinical data
    Harry J de Koning
    Erasmus MC, Department of Public Health, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    Breast Cancer Res 8:202. 2006
  7. ncbi Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer
    J B Madalinska
    Department of Public Health, Erasmus University, Rotterdam, The Netherlands
    J Clin Oncol 19:1619-28. 2001
  8. ncbi Passive coping and psychological distress in women adhering to regular breast cancer surveillance
    K Pieterse
    Department of Medical Psychology and Psychotherapy, Erasmus MC, Rotterdam, The Netherlands
    Psychooncology 16:851-8. 2007
  9. ncbi Breast cancer screening; cost-effective in practice?
    H J de Koning
    Department of Public Health, Erasmus University Rotterdam, The Netherlands
    Eur J Radiol 33:32-7. 2000
  10. ncbi Short-term effects of population-based screening for prostate cancer on health-related quality of life
    M L Essink-Bot
    Department of Public Health, Erasmus University Rotterdam, The Netherlands
    J Natl Cancer Inst 90:925-31. 1998

Research Grants

  1. A trial-based MISCAN model for prostate cancer
    Harry de Koning; Fiscal Year: 2007

Detail Information

Publications106 found, 100 shown here

  1. ncbi Early detection and counselling intervention of asthma symptoms in preschool children: study design of a cluster randomised controlled trial
    Esther Hafkamp-de Groen
    The Generation R Study Group, Erasmus MC, Rotterdam, The Netherlands
    BMC Public Health 10:555. 2010
    ..Early detection and counselling is expected to reduce the prevalence of asthma symptoms and improve health-related quality of life at age 6 years...
  2. ncbi Bracing patients with idiopathic scoliosis: design of the Dutch randomized controlled treatment trial
    Eveline M Bunge
    Erasmus MC, University Medical Center Rotterdam, Dept of Public Health, P O Box 2040, 3000 CA Rotterdam, The Netherlands
    BMC Musculoskelet Disord 9:57. 2008
    ....
  3. ncbi Monitoring the ERSPC trial
    H J de Koning
    Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
    BJU Int 92:112-4. 2003
  4. ncbi Determining the cause of death in randomized screening trial(s) for prostate cancer
    H J de Koning
    Erasmus MC, Department Public Health, Rotterdam, The Netherlands
    BJU Int 92:71-8. 2003
  5. ncbi Mammographic screening: evidence from randomised controlled trials
    H J de Koning
    Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands
    Ann Oncol 14:1185-9. 2003
    ..A summary of the prerequisites for methodological quality and its available evidence from the trials is given. Data to support breast cancer mortality as a correct outcome measure are presented...
  6. ncbi Overdiagnosis and overtreatment of breast cancer: microsimulation modelling estimates based on observed screen and clinical data
    Harry J de Koning
    Erasmus MC, Department of Public Health, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    Breast Cancer Res 8:202. 2006
    ..The increases in ductal carcinoma in situ (DCIS) are primarily due to mammography screening, but DCIS still remains a relatively small proportion of the total breast cancer problem...
  7. ncbi Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer
    J B Madalinska
    Department of Public Health, Erasmus University, Rotterdam, The Netherlands
    J Clin Oncol 19:1619-28. 2001
    ....
  8. ncbi Passive coping and psychological distress in women adhering to regular breast cancer surveillance
    K Pieterse
    Department of Medical Psychology and Psychotherapy, Erasmus MC, Rotterdam, The Netherlands
    Psychooncology 16:851-8. 2007
    ..Coping style was not associated with the trend of psychological distress around the two surveillance appointments. It is recommendable to take coping styles into account when counselling these high-risk women...
  9. ncbi Breast cancer screening; cost-effective in practice?
    H J de Koning
    Department of Public Health, Erasmus University Rotterdam, The Netherlands
    Eur J Radiol 33:32-7. 2000
    ..On a national scale, with hundreds of professional practitioners, it can be expected to be more difficult to attain uniform quality. Continuous quality control, monitoring and evaluation are therefore crucial...
  10. ncbi Short-term effects of population-based screening for prostate cancer on health-related quality of life
    M L Essink-Bot
    Department of Public Health, Erasmus University Rotterdam, The Netherlands
    J Natl Cancer Inst 90:925-31. 1998
    ....
  11. ncbi Cost-effectiveness of different reading and referral strategies in mammography screening in the Netherlands
    J H Groenewoud
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Breast Cancer Res Treat 102:211-8. 2007
    ....
  12. ncbi Women's acceptance of MRI in breast cancer surveillance because of a familial or genetic predisposition
    M L Essink-Bot
    Department of Public Health, Erasmus MC University Medical Center Rotterdam, P O Box 2040, 3000 CA Rotterdam, The Netherlands
    Breast 15:673-6. 2006
    ..MRI provided the most reassurance of breast cancer being absent in case of a favourable test result. MRI seems to be acceptable as a screening test for women at increased breast cancer risk and is preferred by them over mammography...
  13. ncbi Psychological distress and breast self-examination frequency in women at increased risk for hereditary or familial breast cancer
    S Van Dooren
    Department of Medical Psychology and Psychotherapy, Erasmus MC, Rotterdam, The Netherlands
    Community Genet 6:235-41. 2003
    ..Surveillance consists of biannual physical examination, annual mammography, annual MRI and monthly breast self-examination (BSE)...
  14. ncbi Health-related quality of life in patients with screen-detected versus clinically diagnosed prostate cancer preceding primary treatment
    J B Madalinska
    Department of Public Health, Erasmus University Rotterdam, P O Box 1738, 3000 DR Rotterdam, The Netherlands
    Prostate 46:87-97. 2001
    ..The purpose of this study was to evaluate baseline health-related quality of life (HRQOL) in patients with localized prostate cancer before primary treatment (radical prostatectomy or radiotherapy)...
  15. ncbi Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON)
    K A M van den Bergh
    Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, 3000 CA Rotterdam, The Netherlands
    Br J Cancer 102:27-34. 2010
    ..In subjects with either an indeterminate or a negative result after screening, we investigated whether health-related quality of life (HRQoL) changed over time and differed between groups in the short term...
  16. ncbi Informed decision-making in prenatal screening for Down's syndrome: what knowledge is relevant?
    H M H J D Schoonen
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Patient Educ Couns 84:265-70. 2011
    ....
  17. ncbi Generalisability of the results of the Dutch-Belgian randomised controlled lung cancer CT screening trial (NELSON): does self-selection play a role?
    C M van der Aalst
    Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
    Lung Cancer 77:51-7. 2012
    ..Results of the NELSON trial will be roughly applicable to the Dutch and probably other populations that fulfil our selection criteria...
  18. ncbi MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch National Study (MRISC)
    M Kriege
    Rotterdam Family Cancer Clinic, Erasmus MC (University Medical Centre Rotterdam)/Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands
    Fam Cancer 1:163-8. 2001
    ..The aim is to include 2,500 women. The study started on 1 November 1999. On 1 January 2002, more than 1,700 women, including 210 proven carriers of a BRCA1 or BRCA2 mutation, were included in the study...
  19. ncbi To be screened or not to be screened? Modeling the consequences of PSA screening for the individual
    E M Wever
    Department of Public Health, Erasmus Medical Center, PO Box 2040, Rotterdam 3000 CA, The Netherlands
    Br J Cancer 107:778-84. 2012
    ..We estimated benefits and adverse effects of PSA screening for individuals who are deciding whether or not to be screened...
  20. ncbi Prediction of higher mortality reduction for the UK Breast Screening Frequency Trial: a model-based approach on screening intervals
    N T van Ravesteyn
    Department of Public Health, Erasmus MC, PO Box 2040, Rotterdam 3000 CA, The Netherlands
    Br J Cancer 105:1082-8. 2011
    ..In this study, the trial is simulated in order to gain insight into the results of the trial and to predict the effect of different screening intervals on breast cancer mortality...
  21. ncbi Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer
    E A M Heijnsdijk
    Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    Br J Cancer 101:1833-8. 2009
    ..Overdetection and overtreatment are substantial unfavourable side effects with consequent healthcare costs. In this study the effects of introducing widespread PSA screening is evaluated...
  22. ncbi Including the quality-of-life effects in the evaluation of prostate cancer screening: expert opinions revisited?
    M L Essink-Bot
    Department of Public Health, Erasmus MC University Medical Centre Rotterdam, The Netherlands
    BJU Int 92:101-5. 2003
    ..g. the EQ-5D) and linking these descriptions to utility estimates using the standard preference-based algorithm, combining them with the appropriate duration into quality-adjusted life years, and sensitivity analysis...
  23. ncbi Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial
    K A M van den Bergh
    Dept of Public Health, Erasmus MC, University Medical Centre Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    Eur Respir J 38:154-61. 2011
    ....
  24. ncbi Breast cancer screening in Navarra: interpretation of a high detection rate at the first screening round and a low rate at the second round
    M E van den Akker-van Marle
    Department of Public Health, Erasmus University Rotterdam, The Netherlands
    Int J Cancer 73:464-9. 1997
    ..Interval cancer rates, results of the subsequent round and size distributions are also crucial indicators of the quality of the screening programme and should be analysed in their specific context...
  25. ncbi Mammography requests in general practice during the introduction of nationwide breast cancer screening, 1988-1995
    P M Beemsterboer
    Department of Public Health, Erasmus University Rotterdam, The Netherlands
    Eur J Cancer 35:450-4. 1999
    ..Opportunistic screening was not clearly demonstrated in adjacent age groups...
  26. ncbi Decreased rates of advanced breast cancer due to mammography screening in The Netherlands
    J Fracheboud
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 1753, NL 3000 DR Rotterdam, The Netherlands
    Br J Cancer 91:861-7. 2004
    ..It is evident that breast cancer screening contributes to a reduction in advanced breast cancers and breast cancer mortality...
  27. ncbi Interval cancers in the Dutch breast cancer screening programme
    J Fracheboud
    Department of Public Health, Erasmus University Rotterdam, The Netherlands
    Br J Cancer 81:912-7. 1999
    ..Measures should be considered to improve the detection of small invasive cancers and to reduce false-negative rates, even if this will lead to increasing referral rates...
  28. ncbi Blinded and uniform causes of death verification in cancer screening: a major influence on the outcome of a prostate cancer screening trial?
    S J Otto
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Eur J Cancer 46:3061-7. 2010
    ....
  29. ncbi Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality
    M M Vervoort
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, and Netherlands Institute for Health Sciences, The Netherlands
    Br J Cancer 91:242-7. 2004
    ..In conclusion, although adjuvant systemic therapy can reduce breast cancer mortality rates, it is anticipated to be less than the mortality reduction caused by mammography screening...
  30. ncbi Impact of screening for breast cancer in high-risk women on health-related quality of life
    A J Rijnsburger
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    Br J Cancer 91:69-76. 2004
    ..In this study, high-risk women who opted for regular breast cancer screening had a better health status than women from the general population...
  31. ncbi PSA levels and cancer detection rate by centre in the European Randomized Study of Screening for Prostate Cancer
    S J Otto
    Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, P O Box 2040, 3000 CA Rotterdam, The Netherlands
    Eur J Cancer 46:3053-60. 2010
    ..To describe the variation in PSA level by age group and screening round in the ERSPC centres and the variation in cancer detection rates in relation to the underlying prostate cancer incidence...
  32. ncbi Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-up
    I J Korfage
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    Br J Cancer 94:1093-8. 2006
    ..STAI-State can be a useful screening tool but needs further development...
  33. ncbi Measuring psychological consequences of screening: adaptation of the psychological consequences questionnaire into Dutch
    A J Rijnsburger
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Qual Life Res 15:933-40. 2006
    ..To assess the psychometric properties of a Dutch adaptation of an originally Australian instrument measuring the psychological impact of breast cancer screening...
  34. ncbi The impact of a lung cancer computed tomography screening result on smoking abstinence
    C M van der Aalst
    Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    Eur Respir J 37:1466-73. 2011
    ..Screening test outcomes could be used as a teachable moment for smoking cessation...
  35. ncbi Chapter 7: Description of MISCAN-lung, the Erasmus MC Lung Cancer microsimulation model for evaluating cancer control interventions
    F W Schultz
    Erasmus MC, Department of Public Health, Rotterdam, The Netherlands
    Risk Anal 32:S85-98. 2012
    ..The model fits in the actual tobacco-control scenario, providing credibility to the estimates of other scenarios, although considering survey-reported smoking trends alone has limitations...
  36. ncbi Does participation to screening unintentionally influence lifestyle behaviour and thus lifestyle-related morbidity?
    C M van der Aalst
    Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Dr Molewaterplein 50, 3015 GE Rotterdam, The Netherlands
    Best Pract Res Clin Gastroenterol 24:465-78. 2010
    ..Integrated approaches to combine primary and secondary prevention have the potential to optimise the efforts to improve cancer prevention and survival. More research is warranted to investigate evidence-based approaches...
  37. ncbi Population-based mammography screening below age 50: balancing radiation-induced vs prevented breast cancer deaths
    R de Gelder
    Erasmus MC, Department of Public Health, P O Box 2040, 3000 CA, Rotterdam, The Netherlands
    Br J Cancer 104:1214-20. 2011
    ..Because the radiation risk increases with lower exposure age, advancing the lower age limit may affect the balance between screening benefits and risks. The present study explores the benefit-risk ratio of screening before age 50...
  38. ncbi Changes in use of breast-conserving therapy in years 1978-2000
    H J de Koning
    Department of Public Health, Erasmus Universiteit, Rotterdam, The Netherlands
    Br J Cancer 70:1165-70. 1994
    ..Given the rapidity of change towards the use of breast-conserving surgery, which is enhanced by screening, recent information will be needed in predicting capacity and assessing whether screen-detected women are treated adequately...
  39. ncbi Detecting language problems: accuracy of five language screening instruments in preschool children
    H M E van Agt
    Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
    Dev Med Child Neurol 49:117-22; discussion 84. 2007
    ..The area under the ROC curves, ranged from 0.75 to 0.87. Apparently, short and simple parent report instruments like the LSI-PF and the one-item VAS perform remarkably well in detecting language delays in preschool children...
  40. ncbi Blinded and uniform cause of death verification in a lung cancer CT screening trial
    N Horeweg
    Department of Public Health, Erasmus MC Rotterdam, P O Box 2040, 3000 CA Rotterdam, The Netherlands
    Lung Cancer 77:522-5. 2012
    ..Our results imply that the final outcome of a lung cancer screening trial cannot reliably be established without predetermined criteria and an independent review of blinded cases...
  41. ncbi Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer
    M Kriege
    Department of Medical Oncology, Rotterdam Family Cancer Clinic, Erasmus MC Daniel den Hoed Cancer Centre, Groene Hilledijk 301, 3075 EA, Rotterdam, The Netherlands
    Breast Cancer Res Treat 102:357-63. 2007
    ....
  42. ncbi MISCAN: estimating lead-time and over-detection by simulation
    G Draisma
    Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, The Netherlands
    BJU Int 92:106-11. 2003
    ..To estimate the mean lead-time and rate of over-detection associated with screening for prostate cancer with prostate-specific antigen...
  43. ncbi Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram
    E W Steyerberg
    Department of Public Health, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands
    J Urol 177:107-12; discussion 112. 2007
    ..Statistical models have been proposed to predict indolent cancer. We validated and updated model predictions for a screening setting...
  44. ncbi Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM)
    M J Roobol
    Department of Urology, Erasmus Medical Centre Rotterdam, Netherlands Institute for Health Sciences, Rotterdam, The Netherlands
    Urology 63:309-13; discussion 313-5. 2004
    ..The PSA velocity did not appear to be a useful screening tool for the identification of these cancers...
  45. ncbi Cost-effectiveness of stereotactic large-core needle biopsy for nonpalpable breast lesions compared to open-breast biopsy
    J H Groenewoud
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    Br J Cancer 90:383-92. 2004
    ....
  46. ncbi Low all-cause mortality in the volunteer-based Rotterdam section of the European randomised study of screening for prostate cancer: self-selection bias?
    S J Otto
    Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    J Med Screen 11:89-92. 2004
    ..In addition, the accuracy of the randomisation was evaluated by comparison amongst the trial arms...
  47. ncbi A cluster-randomised trial of screening for language disorders in toddlers
    H J de Koning
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands
    J Med Screen 11:109-16. 2004
    ..Short-term health benefits could not be demonstrated. Large-scale introduction cannot be recommended on the basis of this information alone...
  48. ncbi [Multi-detector CT screening for lung cancer is still to be discouraged for the time being]
    R J van Klaveren
    Erasmus MC Centrum, Rotterdam
    Ned Tijdschr Geneeskd 152:125-8. 2008
    ....
  49. ncbi Informed decision-making about the fetal anomaly scan: what knowledge is relevant?
    H M H J D Schoonen
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Ultrasound Obstet Gynecol 37:649-57. 2011
    ..The second was to compare the contents of decision-relevant knowledge for second-trimester ultrasound screening with those for first-trimester screening for Down syndrome using the combined test...
  50. ncbi Informed participation in a randomised controlled trial of computed tomography screening for lung cancer
    K A M van den Bergh
    Dept of Public Health, Erasmus MC, University Medical Centre Rotterdam, The Netherlands
    Eur Respir J 34:711-20. 2009
    ..Additional efforts are required to improve the knowledge and understanding of subjects who are in the process of decision-making regarding participation in a lung cancer screening trial...
  51. ncbi Measuring disease specific quality of life in localized prostate cancer: the Dutch experience
    I J Korfage
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Qual Life Res 12:459-64. 2003
    ..We aimed at developing and testing a Dutch health-related quality of life measure for localized prostate cancer patients...
  52. ncbi School-based internet-tailored fruit and vegetable education combined with brief counselling increases children's awareness of intake levels
    Resiti T Mangunkusumo
    Department of Public Health, Erasmus MC University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands
    Public Health Nutr 10:273-9. 2007
    ..This study applied Internet-tailored advice for schoolchildren and Internet-supported brief dietary counselling (with child and parent) within preventive health care to promote fruit/vegetable intake...
  53. ncbi Side-effects of treatment for localized prostate cancer: are they valued differently by patients and healthy controls?
    Ida J Korfage
    Department of Public Health, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands
    BJU Int 99:801-6. 2007
    ....
  54. ncbi How to deal with incidentally detected pulmonary nodules less than 10mm in size on CT in a healthy person
    Susan C Van't Westeinde
    Department of Pulmonology, Erasmus MC Rotterdam, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    Lung Cancer 60:151-9. 2008
    ..Growing lesions with a volume doubling time <400 days require further work-up and diagnosis, otherwise an annual repeat scan to assess growth is recommended...
  55. ncbi Additional double reading of screening mammograms by radiologic technologists: impact on screening performance parameters
    Lucien E M Duijm
    Department of Radiology, Catharina Hospital, PO Box 1350, 5602 ZA, Eindhoven, The Netherlands
    J Natl Cancer Inst 99:1162-70. 2007
    ..We prospectively examined the effects on screening performance of adding independent double reading of screening mammograms by technologists to standard double reading by radiologists...
  56. ncbi Health-related quality of life in adolescents with wheezing attacks
    Ashna D Mohangoo
    Department of Public Health, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands
    J Adolesc Health 41:464-71. 2007
    ....
  57. ncbi A cluster-randomized trial of screening for language delay in toddlers: effects on school performance and language development at age 8
    Heleen M E van Agt
    Department of Public Health, Erasmus MC, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    Pediatrics 120:1317-25. 2007
    ..The goal of this study was to assess the effects of screening and early treatment of preschool children for language delay on language development and school performance at age 8...
  58. ncbi Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India
    Quirine Lamberts Okonkwo
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    J Natl Cancer Inst 100:1290-300. 2008
    ..Estimates and comparisons of the cost-effectiveness of feasible breast cancer screening policies in developing countries and identification of the determinants of cost and efficacy are needed...
  59. ncbi Impressive time-related influence of the Dutch screening programme on breast cancer incidence and mortality, 1975-2006
    Johannes D M Otten
    Department of Epidemiology, Biostatistics and Health Technology Assessment, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Int J Cancer 123:1929-34. 2008
    ..The results indicate an impressive decrease in breast cancer mortality in the age group invited for breast cancer screening, starting to show quite soon after implementation...
  60. ncbi Effect of nodule characteristics on variability of semiautomated volume measurements in pulmonary nodules detected in a lung cancer screening program
    Ying Wang
    Department of Radiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Radiology 248:625-31. 2008
    ..To retrospectively assess volume measurement variability in solid pulmonary nodules (volume, 15-500 mm(3)) detected at lung cancer screening and to quantify the independent effects of nodule morphology, size, and location...
  61. ncbi Impact of computed tomography screening for lung cancer on participants in a randomized controlled trial (NELSON trial)
    Karien A M van den Bergh
    Department of Public Health, Erasmus MC University Medical Centre Rotterdam, Rotterdam, The Netherlands
    Cancer 113:396-404. 2008
    ..In the current study, the authors assessed the discomfort associated with CT scanning and the subsequent wait for results and health-related quality of life (HRQoL) over time...
  62. ncbi Breast cancer screening: evidence for false reassurance?
    Rianne De Gelder
    Department of Public Health, Erasmus MC, 3000 CA Rotterdam, The Netherlands
    Int J Cancer 123:680-6. 2008
    ..0 days (95% C.I. 5.9-8.1) in symptomatic screened patients and 6.0 days (95% C.I. 4.0-8.0) in control patients. Our results show that false reassurance played, at most, only a minor role in breast cancer screening...
  63. ncbi Effective PSA contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer
    Suzie J Otto
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Int J Cancer 105:394-9. 2003
    ..Although the reasons for ordering PSA test or indicating biopsy are unknown, effective PSA contamination in the Rotterdam ERSPC section is low and not likely to jeopardize the power of the trial...
  64. ncbi Introduction of additional double reading of mammograms by radiographers: effects on a biennial screening programme outcome
    Lucien E M Duijm
    Department of Radiology, Catharina Hospital, Eindhoven, The Netherlands
    Eur J Cancer 44:1223-8. 2008
    ..To determine the effect of introducing radiographer double reading, in addition to standard radiologist double reading, on screening mammography outcome...
  65. ncbi Does "normal" aging imply urinary, bowel, and erectile dysfunction? A general population survey
    Ida J Korfage
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Urology 72:3-9. 2008
    ..We assessed if urinary, bowel, and sexual dysfunction and associated bother were part of the "normal" aging process in the general male Dutch population...
  66. ncbi Estimating the effectiveness of screening for scoliosis: a case-control study
    Eveline M Bunge
    Department of Public Health, Erasmus Medical Center, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    Pediatrics 121:9-14. 2008
    ..The aim of this study was to test the hypothesis that screening for scoliosis is effective in reducing the need for surgical treatment...
  67. ncbi Response shift due to diagnosis and primary treatment of localized prostate cancer: a then-test and a vignette study
    Ida J Korfage
    Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands
    Qual Life Res 16:1627-34. 2007
    ..Whether a prostate cancer diagnosis induces response shift has not been established so far. Therefore, we assessed response shift in men who were diagnosed with localized prostate cancer...
  68. ncbi A decade of breast cancer screening in The Netherlands: trends in the preoperative diagnosis of breast cancer
    Lucien E M Duijm
    Department of Radiology, Catharina Hospital, PO Box 1350, 5602 ZA, Eindhoven, The Netherlands
    Breast Cancer Res Treat 106:113-9. 2007
    ..In a prospective, multi-institutional follow-up study we describe the trends in the preoperative pathologic confirmation of breast cancer of women who underwent breast cancer screening between 1995 and 2005...
  69. ncbi Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON)
    Carola A Van Iersel
    Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
    Int J Cancer 120:868-74. 2007
    ..When pooling with Danish trial data (n = +/-4,000) NELSON is the only trial without screening in controls that is expected to have 80% power to show a lung cancer mortality reduction of at least 25% 10 years after randomisation...
  70. ncbi Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators
    Johannes D M Otten
    Department of Epidemiology and Biostatistics, Radboud University Nijmegen Medical Centre, P O Box 9101, 6500 HB Nijmegen, The Netherlands
    J Natl Cancer Inst 97:748-54. 2005
    ..To estimate the effect of changes in recall rate on earlier detection of cancers, we carried out a blinded review of interval and screen-detected cancers in the Dutch screening program...
  71. ncbi Rotterdam randomized pilot studies of screening for prostate cancer--an overview after 10 years
    Fritz H Schroder
    J Natl Cancer Inst 97:696. 2005
  72. ncbi Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer
    Ida J Korfage
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Int J Cancer 116:291-6. 2005
    ..Scores of both patient groups remained above those of norm populations. Innovative graphs describing disease-specific and generic functions after treatment can help patients and physicians in their treatment choices...
  73. ncbi The impact of having relatives affected with breast cancer on psychological distress in women at increased risk for hereditary breast cancer
    Silvia van Dooren
    Department of Medical Psychology and Psychotherapy, Erasmus MC, Rotterdam, The Netherlands
    Breast Cancer Res Treat 89:75-80. 2005
    ..Being at hereditary risk of breast cancer (BC) may lead to elevated levels of distress because of the impact of the BC-process in relatives...
  74. ncbi Internet-administered adolescent health questionnaires compared with a paper version in a randomized study
    Resiti T Mangunkusumo
    Department of Public Health, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands
    J Adolesc Health 36:70.e1-6. 2005
    ..Furthermore, it compares adolescents' evaluations of modes of administration...
  75. ncbi Psychological distress in women at increased risk for breast cancer: the role of risk perception
    Silvia van Dooren
    Department of Medical Psychology and Psychotherapy, Erasmus MC, Rotterdam, The Netherlands
    Eur J Cancer 40:2056-63. 2004
    ..This knowledge should be used during surveillance appointments in order to improve and individualise support for these women...
  76. ncbi Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition
    Mieke Kriege
    Rotterdam Family Cancer Clinic, Department of Medical Oncology, Erasmus Medical Center-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    N Engl J Med 351:427-37. 2004
    ..4 percent (P<0.001) and 56.4 percent (P=0.001) in the two control groups. CONCLUSIONS: MRI appears to be more sensitive than mammography in detecting tumors in women with an inherited susceptibility to breast cancer...
  77. ncbi Mammography benefit in the Canadian National Breast Screening Study-2: a model evaluation
    Adriana J Rijnsburger
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Int J Cancer 110:756-62. 2004
    ..6-34.1%. Enrolled women had above average risk. Screening sensitivity in both arms was high. A benefit of mammography screening is supported by our modeling of the CNBSS-2 results...
  78. ncbi Update on screening and early detection of prostate cancer
    Suzie J Otto
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Curr Opin Urol 14:151-6. 2004
    ..The aim of this review is to discuss advances in the field of screening and early detection of prostate cancer from papers published in 2003...
  79. ncbi Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer
    Gerrit Draisma
    Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
    J Natl Cancer Inst 95:868-78. 2003
    ..Both consequences have considerable impact on the net benefits of screening...
  80. ncbi Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review
    Suzie J Otto
    Department of Public Health, Erasmus MC, University Medical Centre, Rotterdam, Netherlands
    Lancet 361:1411-7. 2003
    ..INTERPRETATION: Routine mammography screening can reduce breast-cancer mortality rates in women aged 55-74 years...
  81. ncbi Lung cancer screening by spiral CT. What is the optimal target population for screening trials?
    Rob J van Klaveren
    Department of Pulmonology, Erasmus Medical Centre, University Hospital Rotterdam, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
    Lung Cancer 38:243-52. 2002
    ..The inadequacy of the unit 'Pack-Years' (PY) to estimate the individual lung cancer risk is recognised, and future initiatives to develop an appropriate lung cancer risk model are encouraged...
  82. ncbi Prostate cancer mortality reduction by screening: power and time frame with complete enrollment in the European Randomised Screening for Prostate Cancer (ERSPC) trial
    Harry J de Koning
    Department of Public Health, Erasmus University Medical Centre Rotterdam, Rotterdam, The Netherlands
    Int J Cancer 98:268-73. 2002
    ..If early detection and treatment turns out to have a stronger effect as may be suggested by observational data, the ERSPC trial is likely to conclusively show that within the next 5 years...
  83. ncbi Should we start population screening for prostate cancer? Randomised trials are still needed
    Anssi Auvinen
    School of Public Health, FIN 33014 University of Tampere, Tampere, Finland
    Int J Cancer 97:377-8. 2002
  84. ncbi Exploring the course of psychological distress around two successive control visits in women at hereditary risk of breast cancer
    Silvia van Dooren
    Department of Medical Psychology and Psychotherapy, Erasmus MC, Rotterdam, The Netherlands
    Eur J Cancer 41:1416-25. 2005
    ..The course of general distress differed significantly for women closely involved in a sister's BC-process. These more vulnerable subgroups may be in need of extra counselling and care...
  85. ncbi Comparison of screen detected and clinically diagnosed prostate cancer in the European randomized study of screening for prostate cancer, section rotterdam
    Ingrid W van der Cruijsen-Koeter
    Departments of Urology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
    J Urol 174:121-5. 2005
    ..CONCLUSIONS: Although a favorable shift in prognostic factors was seen for the screening arm of the trial, these results do not provide evidence that prostate cancer screening has an effect on prostate cancer mortality...
  86. ncbi Hereditary breast cancer growth rates and its impact on screening policy
    Madeleine M A Tilanus-Linthorst
    Department of Surgical Oncology, Erasmus University Medical Centre, Rotterdam, The Netherlands
    Eur J Cancer 41:1610-7. 2005
    ..It is recommended that the screening frequency should be adjusted according to a woman's age and a high-sensitive biannual test may be appropriate before the age of 40 years...
  87. ncbi Risk of cardiovascular mortality in prostate cancer patients in the Rotterdam randomized screening trial
    Suzie J Otto
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    J Clin Oncol 24:4184-9. 2006
    ....
  88. ncbi Overall and disease-specific survival of patients with screen-detected prostate cancer in the European randomized study of screening for prostate cancer, section Rotterdam
    Stijn H de Vries
    Department of Urology, Erasmus MC, Rotterdam, The Netherlands
    Eur Urol 51:366-74; discussion 374. 2007
    ....
  89. ncbi Gleason score, age and screening: modeling dedifferentiation in prostate cancer
    Gerrit Draisma
    Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
    Int J Cancer 119:2366-71. 2006
    ..Tumors dedifferentiate during the screen-detectable phase and consequently screening with PSA and early treatment can possibly prevent dedifferentiation...
  90. ncbi Patients' perceptions of the side-effects of prostate cancer treatment--a qualitative interview study
    Ida Joanna Korfage
    Department of Public Health, ErasmusMC, University Medical Center Rotterdam, P O Box 1738, 3000 DR Rotterdam, Netherlands
    Soc Sci Med 63:911-9. 2006
    ..By presenting these findings we want to draw attention to issues that complicate QoL assessments in general and in prostate cancer patients in particular...
  91. ncbi Factors affecting sensitivity and specificity of screening mammography and MRI in women with an inherited risk for breast cancer
    Mieke Kriege
    Family Cancer Clinic, Department of Medical Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands
    Breast Cancer Res Treat 100:109-19. 2006
    ..227) and for women with a low breast density (0.237). CONCLUSIONS: This report supports the earlier recommendation that MRI should be a standard screening method for breast cancer in BRCA1/2 mutation carriers...
  92. ncbi Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition
    Mieke Kriege
    The Rotterdam Family Cancer Clinic, Department of Medical Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, Netherlands
    Cancer 106:2318-26. 2006
    ..As results of these subsequent screening rounds were most predictive for long-term effects, the authors expect that this screening program will contribute to a decrease of breast cancer mortality in these high-risk women...
  93. ncbi Health-related quality of life in patients with adolescent idiopathic scoliosis after treatment: short-term effects after brace or surgical treatment
    Eveline M Bunge
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, P O Box 2040, 3000 CA, Rotterdam, The Netherlands
    Eur Spine J 16:83-9. 2007
    ..We conclude that short-term differences in HRQoL after treatment in adolescent patients with idiopathic scoliosis are negligible and cannot support preference of one treatment above the other...
  94. ncbi Selective screening for scoliosis
    Eveline M Bunge
    Clin Orthop Relat Res 445:277-8; author reply 278-9. 2006
  95. ncbi Screening for scoliosis: do we have indications for effectiveness?
    Eveline M Bunge
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    J Med Screen 13:29-33. 2006
    ..This study investigated whether patients with adolescent idiopathic scoliosis detected by screening are detected in an earlier stage of the clinical course, and whether these patients have better outcome than otherwise detected patients...
  96. ncbi Quality of life of children with language delays
    Heleen M E van Agt
    Department of Public Health, Erasmus MC, Rotterdam, The Netherlands
    Qual Life Res 14:1345-55. 2005
    ..These results provide additional evidence for the importance of monitoring the language development and its consequences during childhood...
  97. ncbi Health-related quality of life in preschool children with wheezing and dyspnea: preliminary results from a random general population sample
    Ashna D Mohangoo
    Department of Public Health, Erasmus MC University Medical Center Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    Qual Life Res 14:1931-6. 2005
    ..05). In conclusion, decreases in HRQOL among preschoolers with parent-reported respiratory symptoms are measurable with the TAPQOL. We recommend studying the impact of doctor-diagnosed respiratory symptoms on HRQOL in future studies...
  98. ncbi Seventy-five years is an appropriate upper age limit for population-based mammography screening
    Jacques Fracheboud
    Department of Public Health, NETB, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
    Int J Cancer 118:2020-5. 2006
    ..At present, 75 years of age can be regarded as an appropriate upper age limit for the Dutch programme...
  99. ncbi Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial
    Harry J de Koning
    Department of Public Health, Erasmus University Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    Int J Cancer 97:237-44. 2002
    ..The differences between countries seem to reflect both underlying prostate cancer incidence and screening policy. The trials have the power to show definitive results in 2005-2008...
  100. ncbi Prostate cancer diagnosis: the impact on patients' mental health
    Ida J Korfage
    Department of Public Health, Erasmus MC, University Medical Center Rotterdam, P O Box 1738, 3000 DR Rotterdam, The Netherlands
    Eur J Cancer 42:165-70. 2006
    ..The methodological implication is that considering a post-diagnosis assessment as 'baseline' may lead to an underestimation of the patient's mental health...

Research Grants3

  1. A trial-based MISCAN model for prostate cancer
    Harry de Koning; Fiscal Year: 2007
    ..Finally the model will be used to identify optimal screening and treatment strategies. ..